Vitruvia Medical AG Strengthens Financial Structure Through Capital Increase

Vitruvia Medical AG has announced a successful capital increase completed on December 15, 2025. The raised capital was fully allocated to repay a convertible bond maturing in early December. This strategic move enhanced the company's equity position and significantly reduced its debt load.

The bolstered capital structure ensures Vitruvia's long-term financing capabilities and contributes to its economic stability. By repaying the bond, the company reinforces its financial foundation, maintaining a focus on sustainable growth and operational resilience.

Vitruvia's Board of Directors emphasizes the importance of this financial strengthening in supporting the company's ongoing business objectives and future expansions.